Mate Tablet (Talniflumate)

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

This medication must be consulted with a doctor or pharmacist before use by individuals who regularly consume more than three alcoholic beverages daily. This is because gastrointestinal bleeding may occur when taking this medication. This medication may increase the risk of cardiovascular diseases. Serious cardiovascular issues such as myocardial infarction or stroke may occur, so individuals with cardiovascular diseases or risk factors should be especially cautious. If cardiovascular symptoms appear during use, immediate medical attention is required. This medication can cause serious adverse reactions such as gastrointestinal bleeding, ulcers, and perforation. The risk may be higher in elderly patients or those taking the medication for a long time, thus careful observation for symptoms of gastrointestinal bleeding is necessary. Individuals with a history of gastrointestinal bleeding or ulcers should not take this medication. This medication should not be administered to individuals with a history of peptic ulcers, allergies to this medication or its components, asthmatics, individuals with hypersensitivity to aspirin, those with severe liver, kidney, or heart diseases, pregnant or breastfeeding women, and individuals with certain genetic disorders. Patients with slightly impaired liver or kidney function, those taking diuretics, and elderly individuals should use this medication cautiously. Attention is also needed for those with a history of allergies. Gastrointestinal adverse reactions such as nausea, vomiting, diarrhea, and abdominal pain may occur during use. Rarely, cardiovascular issues, skin rashes, hives, dizziness, and decreased kidney function may appear. In case of severe skin reactions or serious allergic reactions such as anaphylaxis, the use of the medication should be stopped immediately, and medical advice should be sought. It is advisable to take this medication at the minimum effective dose and for the shortest duration possible. If taken long-term, regular blood tests, as well as liver and kidney function tests, are necessary. It is recommended not to take this medication together with other anti-inflammatory painkillers, and interactions may occur with certain medications (ACE inhibitors, aspirin, diuretics, lithium, methotrexate, warfarin, etc.), so consulting a doctor is mandatory. During pregnancy, especially in the late stages, this medication can pose risks to the fetus and should not be taken. Breastfeeding women should avoid it due to lack of established safety. This medication should not be given to children under 12 years old, and elderly individuals should take it with caution at the minimum effective dose. This medication should be stored out of reach of children, and it is safer not to transfer it to another container.

• Nausea
• vomiting
• photosensitivity
• asthma attack
• hypotension
• general malaise
• hypersensitivity shock
• diarrhea
• abdominal distension
• constipation

This medication should be stored in a sealed container that does not allow air to enter and kept at a temperature between 1°C and 30°C at room temperature. Proper storage will help maintain the efficacy and safety of the medication.

Appearance

Orange circular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle